DNA-guided CRISPR–Cas12a Effectors for Programmable RNA Recognition and Cleavage
Researchers have successfully reprogrammed the CRISPR–Cas12a nuclease system to utilize synthetic DNA guides (crDNA) for targeting and cleaving RNA, a significant departure from its natural RNA-guided mechanism. Published in Nature Biotechnology, this study demonstrates that Cas12a can form a functional deoxyribonucleoprotein complex when engaged with specific DNA structures, leveraging protospacer-adjacent motif (PAM) interactions for activation. Structural, biophysical, and biochemical analyses reveal a distinct molecular activation pathway compared to canonical systems. This innovative approach enables direct RNA detection and efficient intracellular RNA knockdown. By decoupling the informational role of the guide from the structural role of PAM engagement, the research establishes a modular activation architecture for CRISPR–Cas12a. This breakthrough expands the design space for programmable RNA manipulation, offering new potential applications in biomedical engineering, infectious disease diagnostics, and nucleic-acid therapeutics. The findings challenge the longstanding assumption that RNA guides are fundamental for Cas activity, opening new avenues for synthetic biology and molecular biology interventions.
Wire timeline
DNA-guided CRISPR–Cas12a Effectors for Programmable RNA Recognition and Cleavage
Researchers have successfully reprogrammed the CRISPR–Cas12a nuclease system to utilize synthetic DNA guides (crDNA) for targeting and cleaving RNA, a significant departure from its natural RNA-guided mechanism. Published in Nature Biotechnology, this study demonstrates that Cas12a can form a functional deoxyribonucleoprotein complex when engaged with specific DNA structures, leveraging protospacer-adjacent motif (PAM) interactions for activation. Structural, biophysical, and biochemical analyses reveal a distinct molecular activation pathway compared to canonical systems. This innovative approach enables direct RNA detection and efficient intracellular RNA knockdown. By decoupling the informational role of the guide from the structural role of PAM engagement, the research establishes a modular activation architecture for CRISPR–Cas12a. This breakthrough expands the design space for programmable RNA manipulation, offering new potential applications in biomedical engineering, infectious disease diagnostics, and nucleic-acid therapeutics. The findings challenge the longstanding assumption that RNA guides are fundamental for Cas activity, opening new avenues for synthetic biology and molecular biology interventions.
Nature Biotechnology